Markets:

Overview

News

Currencies

International

Treasuries

SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

4.680 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SciSparc Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

April 11, 2024

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results.

Via Benzinga

SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification ↗

April 11, 2024

SciSparc to acquire AutoMax Motors, forming a new entity with SciSparc owning over 50%. SciSparc's core operations to continue.

Via Benzinga

SciSparc to Acquire AutoMax

April 11, 2024

From SciSparc Ltd

Via GlobeNewswire

Why Is SciSparc (SPRC) Stock Up 50% Today? ↗

January 24, 2024

News of an investment fund inking an equity purchase agreement with SciSparc is boosting underlying credibility and lifting SPRC stock.

Via InvestorPlace

Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket ↗

April 11, 2024

Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant...

Via Benzinga

SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression

March 27, 2024

From SciSparc Ltd

Via GlobeNewswire

SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research

March 21, 2024

From SciSparc Ltd

Via GlobeNewswire

SciSparc Granted Another Patent, Strengthening its Core Technology in Canada

March 18, 2024

From SciSparc Ltd

Via GlobeNewswire

SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial

March 14, 2024

From SciSparc Ltd

Via GlobeNewswire

Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors ↗

March 12, 2024

Via Benzinga

SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure

March 12, 2024

From SciSparc Ltd

Via GlobeNewswire

Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments ↗

March 08, 2024

The first patient has been enrolled in SciSparc Ltd.'s clinical trial evaluating the effectiveness and safety of their CBD-based drug for treating children with autism spectrum disorder, marking a...

Via Benzinga

Topics Intellectual Property

SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder

March 08, 2024

From SciSparc Ltd

Via GlobeNewswire

SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe

March 07, 2024

From SciSparc Ltd

Via GlobeNewswire

SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology

March 06, 2024

From SciSparc Ltd

Via GlobeNewswire

Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More ↗

March 04, 2024

Via Benzinga

SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing

February 29, 2024

From SciSparc Ltd

Via GlobeNewswire

SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds

February 27, 2024

From SciSparc Ltd

Via GlobeNewswire

Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds

February 27, 2024

From Clearmind Medicine Inc.

Via GlobeNewswire

EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds ↗

February 27, 2024

Patent applications by Clearmind Medicine for novel compositions in collaboration with SciSparc. Clearmind's CEO, highlights the significant expansion of IP protection.

Via Benzinga

Topics Intellectual Property

Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents ↗

February 21, 2024

SciSparc & Clearmind file patents for LSD, psilocybin, DMT blends, advancing psychedelic therapeutics for mental health.

Via Benzinga

Topics Intellectual Property

What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock? ↗

February 20, 2024

SciSparc Ltd. and Clearmind Medicine Inc. shares are trading higher Tuesday after the companies announced the submission of three international patent applications as part of the ongoing collaboration...

Via Benzinga

Topics Intellectual Property

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 20, 2024

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

Via Benzinga

Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds

February 20, 2024

From Clearmind Medicine Inc.

Via GlobeNewswire

SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds

February 20, 2024

From SciSparc Ltd

Via GlobeNewswire

SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder

January 29, 2024

From SciSparc Ltd

Via GlobeNewswire

Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More ↗

January 26, 2024

Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and online course available.

Via Benzinga

Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 24, 2024

Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares...

Via Benzinga

Crude Oil Rises Over 1%; DuPont Shares Plunge ↗

January 24, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Wednesday. The Dow traded up 0.36% to 38,040.66 while the NASDAQ rose 0.97% to 15,574.97. The...

Via Benzinga

Topics Stocks

Why SciSparc Stock Is Lighting Up ↗

January 24, 2024

SciSparc Ltd. shares are trading higher Wednesday after the company announced that it has entered into a standby equity purchase agreement with YA II PN, Ltd., a fund managed by Yorkville Advisors...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.